COVID-19 Vaccine Response in People with Multiple Sclerosis.
Ann Neurol
; 91(1): 89-100, 2022 01.
Article
in En
| MEDLINE
| ID: mdl-34687063
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Immunocompromised Host
/
Antirheumatic Agents
/
Seroconversion
/
COVID-19 Vaccines
/
COVID-19
/
Multiple Sclerosis
Type of study:
Guideline
/
Prognostic_studies
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Europa
Language:
En
Journal:
Ann Neurol
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: